Tag: ARTX

Finance

NASDAQ Bullish Stocks: JA Solar Holdings (NASDAQ:JASO), Arotech Corporation (NASDAQ:ARTX), dELiA*s (NASDAQ:DLIA), Quantum Fuel Systems Tech (NASDAQ:QTWW)

JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) on Mar. 3 announced that it will supply 7.8MW of its high-efficiency full square mono solar modules to British Solar Renewables, a U.K.-based developer of large-scale renewable projects, for use on a 7.8MW solar farm in the south-western United Kingdom. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) stock performance was 5.67% in last session and finished the day … Continue reading NASDAQ Bullish Stocks: JA Solar Holdings (NASDAQ:JASO), Arotech Corporation (NASDAQ:ARTX), dELiA*s (NASDAQ:DLIA), Quantum Fuel Systems Tech (NASDAQ:QTWW)

John Bellich
Finance

Industrial Goods Top Gainers: Arotech Corporation (NASDAQ:ARTX), Guanwei Recycling (NASDAQ:GPRC), CECO Environmental (NASDAQ:CECE), H&E Equipment Services (NASDAQ:HEES)

Arotech Corporation (Nasdaq:ARTX), a provider of quality defense and security products for the military, law enforcement and homeland security markets, announced today that its Battery and Power Systems Division has advanced its development of an iron flow battery to provide storage for grid power, following promising results in lab tests. Arotech Corporation (NASDAQ:ARTX) stock performance was 7.03% in last session and finished the day at … Continue reading Industrial Goods Top Gainers: Arotech Corporation (NASDAQ:ARTX), Guanwei Recycling (NASDAQ:GPRC), CECO Environmental (NASDAQ:CECE), H&E Equipment Services (NASDAQ:HEES)

Jayne Crisman
Finance

Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended … Continue reading Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Jason Knox